Los Angeles Capital Management
OPTN

Los Angeles Capital Management’s OptiNose OPTN Stock Holding History

Los Angeles Capital Management’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,138
Closed -$146K – 1561
2021
Q2 		$146K Sell
3,138
-180
-5% -$9.19K ﹤0.01% 1504
2021
Q1 		$184K Buy
+3,318
New +$202K ﹤0.01% 1547

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Los Angeles Capital Management's OPTN Position: Q3 2021 in Review

Los Angeles Capital Management sold out of OptiNose (OPTN) in Q3 2021, closing a stake of 3,138 shares — an estimated $146K sold.

Los Angeles Capital Management first reported a position in OPTN in Q1 2021 and held it in 2 quarters. The position peaked at $184K in Q1 2021. 49 funds tracked by Wall St. Rank hold OPTN as of Q3 2021.

  • Los Angeles Capital Management reported no remaining OptiNose position as of Q3 2021 after selling out during the quarter.
  • Los Angeles Capital Management sold 3,138 OptiNose shares in Q3 2021, an estimated $146K.
  • Los Angeles Capital Management first reported a position in OptiNose in Q1 2021 and held it in 2 quarters.
  • Los Angeles Capital Management's OptiNose position peaked at $184K in Q1 2021.
  • 49 funds tracked by Wall St. Rank held OptiNose as of Q3 2021.

Based on Los Angeles Capital Management's 13F filing for Q3 2021, filed 5 Nov 2021.